Modulation of cell-mediated immune response in B16F-10 melanoma-induced metastatic tumor-bearing C57BL/6 mice by sulforaphane

Immunopharmacology and Immunotoxicology

Volumn 29, Issue 2, 2007, Pages 173-186

  Thejass, P ^a   Kuttan, G ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

Antibody dependent cellular cytotoxicity; Antibody dependent complement mediated cytotoxicity; Cell mediated immunity; Cytokines; Melanoma; Natural killer cells; Proinflammatory cytokines; Sulforaphane

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 2; SULFORAPHANE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CELL ACTIVITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLYSIS; DOWN REGULATION; MALE; MELANOMA; METASTASIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; UPREGULATION;

ANIMALS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTICARCINOGENIC AGENTS; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKIN-2; K562 CELLS; KILLER CELLS, NATURAL; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; THIOCYANATES;

ANIMALIA; MUS;

EID: 34548564432     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970701511728     Document Type: Article

References (39)

1. Nelson, D.S.; Nelson, M. Evasion of host defenses by tumor. Immunol. Cell. Biol. 1987, 65, 287-304.
2. Lala, P.K.; Santer, V.; Libenson, H.;Parhar, R.S. Changes in the host natural killer cell population in mice during tumor development. 1. Kinetics and in vivo significance. Cell Immunol. 1985, 93, 250-264.
3. Gorelik, E.; Wiltrout, R.H.; Okumura, K.; Habu, S.; Herberman, R.B. Role of NK cells in the control of metastatic spread and growth of tumor cells in mice. Int. J. Cancer 1982, 30, 107-112.
4. Hanna, N. Inhibition of experimental tumor metastasis by selective activation of natural killer cells. Cancer Res. 1982, 42, 1337-1342.
5. Balkwill, F.; Mantovani, A. Inflammation and cancer: back to Virchow. Lancet 2001, 357, 539-545.
6. Ben-Baruch, A. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Sem. Cancer Biol. 2006, 16, 38-52.
7. Tsavaris, N.; Kosmas, C.; Vadiaka, M.; Kanelopoulos, P.; Boulamatsis, D. Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br. J. Cancer 2002, 87, 21-27.
8. Santin, A.D.; Hermonat, P.L.; Ravaggi, A.; Bellone, S.; Roman, J.; et al. Effects of concurrent cisplatinum administration during radiotherapy Vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 2000, 48, 997-1006.
9. Sonel, M.; Kuttan, G. Immunomodulatory and antitomor activities of Tinospora cordifolia. Fitoterapia 1999, 70, 35-43.
10. Davis, L.; Kuttan, G. Immunomodulatory activity of Withania somnifera. J. Ethnopharmacol. 2000, 71, 193-202.
11. Sunila, E.S.; Kuttan, G. Immunomodulatory and antitomor activity of Piper longum Linn. and Piperine. J. Ethnopharmacol. 2004, 90, 339-346.
12. Tookey, H.L.; Van Etten, C.H.; Daxenbichler, M.E. Glucosinolates. In Toxic Constituents of Plant Stuffs; Liener, I.E., Ed.; Academic Press: New York, 1980; 103-142.
13. Hecht, S.S. Chemoprevention by isothiocyanates. J. Cell. Biochem. 1995, 22, 195-209.
14. Jakubikova, J.; Bao, Y.; Sedlak, J. Isothiocyanates induce cell cycle arrest, apoptosis and mitochondrial potential depolarization in HL-60 and multi drug resistant cell lines. Anti Cancer Res. 2005, 25, 3375-3386.
15. Xu, C.; Shen, G.; Yuan, X.; Kim, J.H.; Gopalkrishnan A.; ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells. Carcinogenesis 2006, 27, 437-445.
16. Zhang, Y.; Talalay, P.; Cho, C.G.; Posner, G.H. A major inducer of anticarcinogenic protective enzymes from broccoli: Isolation and elucidation of structure. Proc. Natl. Acad. Sci. USA 1992, 89, 2399-2403.
17. Myzak, M.C.; Dashwood, W.M.; Orner, G.A.; Ho, E.; Dashwood, RH. Sulforaphane inhibits histone de acetylase in vivo and suppresses tomorigenesis in Apcmin mice. FASEB J. 2006, 20, 506-508.
18. Kim, S.J.; Kang, S.Y.; Shin, H.H.; Choi, H.S. Sulforaphane inhibits osteoclastogenesis by inhibiting nuclear factor-kappa B. Mol. Cells. 2005, 20, 364-370.
19. Fahey, J.W.; Haristoy, X.; Dolan, P.M.; Kensler, T.W.; Scholtus, I.; Sulforaphane inhibits extracellular, intracellular and antibiotic resistant strains of Helicobacter pylori and prevents benzo (a) pyrene induced stomach tumors. Proc. Natl. Acad. Sci. USA 2002, 99, 7610-7615.
20. Thejass, P.; Kuttan, G. Immunomodulatory activity of Sulforaphane, a naturally occurring isothiocyanate from broccoli (Brassica oleracea). Phytomedicine 2007, 14, 538-545.
21. Thejass, P.; Kuttan, G. Antimetastatic activity of Sulforaphane. Life Sci. 2006, 78, 3043-3050.
22. Kim, Y.B.; Huh, N.D.; Koren, H.S.; Amos, D.B. Natural killing (NK) and antibody dependent cellular cytotoxicity (ADCC) in specific pathogen free (SPF) miniature swine and germ free piglets. 1. Comparison of NK and ADCC. J. Immunol. 1980, 125, 755-762.
23. Gupta, S.K.; Bhattacharya, B. Cytotoxicity assays. In A Handbook of Practical Immunolog; Talwar, G.P., Ed., Vikas Publishing House: New Delhi, 1983; 328-333.
24. North, J.; Bakhsh, I.; Marden, C.; Pittman, H.; Addison, E.; et al. Tumour-primed human natural killer cells lyse NK- resistant tumor targets: evidence of a twostage process in resting NK cell activation. J. Immunol. 2007, 178, 85-94.
25. Brittenden, J.; Heys, S.D.; Ross, J.; Eremin, O. Natural killer cells and cancer. Cancer 1996, 77, 1226-1243.
26. Cooper, M.A.; Fehniger, T.A.; Caligiuri, M.A. The biology of human natural killer cell subsets. Trend Immunol. 2001, 22, 633-640.
27. Moretta, L.; Bottino, C.; Pende, D.; Mingari, M.C.; Biassoni, R.; Moretta, A. Human natural killer cells: their origin, receptors and function. Eur. J. Immunol. 2002, 32, 1205-1211.
28. Talmadge, J.; Meyers, K.M.; Prieur, D.J.; Starkey, J.R. Role of natural killer cells in tumor growth and metastasis: C57BL/6 normal and beige mice. J. Natl. Cancer Inst. 1980. 65, 929-935.
29. Smyth, M.J.; Godfrey, D.I.; Trapani, J.A. A fresh look at tumor immunosurveillance and immunotherapy. Nat. Immunol. 2001. 2, 293-299.
30. Hanna, N.; Burtan, R.C. Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastasis in vivo. J. Immunol. 1981, 127, 1754-1758.
31. Djeu, J.Y.; Heinbaugh, J.A.; Holden, H.T.; Heberman, R.B. Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J. Immunol. 1979, 122, 175-181.
32. Misawa, E.; Sakurai, T.; Yamada, M.; Hayasawa, H.; Motoyoshi, K. Effects of macrophage colony-stimulating factor and interleukin-2 administration on NK1.1 + cells in mice. Int. J. Immunopharmacol. 2000, 22, 967-977.
33. Caligiuri, M.A.; Murray, C.; Robertson, M.J.; Wang, E.; Cochran, K.; Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. J. Clin. Invest.1993, 91, 123-132.
34. Henney, C.S.; Kuribayashi, K.; Kern, D.E.; Gillis, S. Interleukin-2 augments natural killer activity. Nature 1981, 291, 335-338.
35. Mandelboim, O.; Malik, P.; Davis, M.D.; Jo, C.H.; Boyson, J.E.; Strominger, J.L. Human CD16 as a lysis receptor mediating direct natural killer cytotoxicity. Proc. Natl. Acad. Sci. USA 1999, 96, 5640-5644.
36. Fanger, M.W.; Guyre, P.M. Bispecific antibodies for targeted cellular cytotoxicity. Trends Biotechnol. 1991, 9, 375-380.
37. Lazar-Moinar, E.; Toth, S.; Falus, A. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 2000, 12, 547-554.
38. Tilg, H.; Dinarello, C.A.; Mier, J.W. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol. Today 1997, 18, 428-432.
39. Young, M.R.I.; Lozano, Y.; Coogan, M.; Wright, M.; Younge, M.E.; Bagashi, J.M. Stimulation of the metastatic properties of Lewis lung carcinoma cells by autologous granulocyte- macrophage colony-stimulating factor. Int. J. Cancer. 1992, 50, 628-634.